Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

410
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
410
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

350
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
350
Analgesia and Pain Management01:25

Analgesia and Pain Management

776
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
776
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

837
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
837
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

636
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
636
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

1.6K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of a Standardized Patient Team Experience to Improve Student Interprofessional Collaboration and Teamwork.

MedEdPORTAL : the journal of teaching and learning resources·2026
Same author

Medication Overuse Headache in the US: A National Cross-Sectional Survey.

Journal of pain & palliative care pharmacotherapy·2025
Same author

Inpatient Nalbuphine Substitution During Intravenous IV Opioid Shortage for Acute Pain in a Community Hospital: A Retrospective Review.

Journal of pain & palliative care pharmacotherapy·2025
Same author

Patterns of Viral Arthropathy and Myalgia Following COVID-19: A Cross-Sectional National Survey.

Journal of pain research·2022
Same author

A Multi-Site Qualitative Study Examining Pharmacy Student Perspectives on the Opioid Crisis.

American journal of pharmaceutical education·2021
Same author

Addressing challenges to precepting advanced pharmacy practice experience students in the community setting.

Currents in pharmacy teaching & learning·2020

Related Experiment Video

Updated: Sep 1, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.8K

Pharmacist Opioid Dispensing Confidence in an Evolving Practice Landscape.

Christopher M Herndon, Ashley M Riley, Nicole M Gattas

    Journal of Pain & Palliative Care Pharmacotherapy
    |August 17, 2022
    PubMed
    Summary

    Pharmacist comfort dispensing opioids decreased over the past year. Increased complexity of risk mitigation strategies impacts decision-making, highlighting the need for better prescriber-pharmacist communication and patient health information access.

    Keywords:
    OUDdispensingopiateopioidopioid use disorderoverdosepainpharmacistpharmacy

    More Related Videos

    Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
    10:13

    Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

    Published on: November 8, 2024

    2.4K
    Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
    16:02

    Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

    Published on: February 10, 2023

    2.8K

    Related Experiment Videos

    Last Updated: Sep 1, 2025

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
    10:17

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

    Published on: April 23, 2019

    9.8K
    Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
    10:13

    Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

    Published on: November 8, 2024

    2.4K
    Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
    16:02

    Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

    Published on: February 10, 2023

    2.8K

    Area of Science:

    • Pharmacy Practice
    • Pain Management
    • Public Health

    Background:

    • Pharmacists face complex decisions when dispensing opioid prescriptions.
    • Risk mitigation strategies have increased the complexity of these decisions.

    Purpose of the Study:

    • To assess changes in pharmacist comfort levels with dispensing opioid prescriptions over the preceding year.

    Main Methods:

    • A cross-sectional, multi-state survey was distributed to pharmacists.
    • 195 community/retail pharmacists completed the 16-item questionnaire in November 2018.

    Main Results:

    • 42.5% of pharmacists reported a decrease in comfort dispensing opioids.
    • 19.6% reported increased comfort, and 38.0% reported no change.
    • Key information for increased comfort includes diagnosis, MME, prior treatments, and PDMP verification.

    Conclusions:

    • Pharmacist comfort with opioid dispensing has declined.
    • Enhanced prescriber-pharmacist communication and patient health information access are crucial for patient care.